Detection of Influenza A H3N2 virus
In response to the emergence of variants of influenza A […]
In response to the emergence of variants of influenza A […]
Focusing on research and development of revolutionary diagnostic technologies since 2011, Credo Diagnostics develops, manufactures, and commercializes accurate, rapid, and affordable molecular diagnostic solutions at the Point-Of-Care testing.
© 2023 | Credo Diagnostics Biomedical Pte. Ltd.
